This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,063.65, is for the delivery of Pimecrolimus 1% Cream 100GM, a specialty pharmaceutical product. The contract is a delivery order and has a firm fixed price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pimecrolimus 1% Cream 30GM to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,431.28, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999, that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Pimecrolimus 1% Cream 30GM, a pharmaceutical product, with a ceiling value of $1,322.25 and a period of performance through March 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,044.96, is for the delivery of Pimecrolimus 1% Cream 100GM, a pharmaceutical product, and was awarded on December 21, 2023 with a completion date of December 22, 2023. The contract is a Delivery Order under a Firm Fixed Price contract type. This award is part of a larger Indefinite Delivery...
This federal contract award, valued at $2,494.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PIMECROLIMUS 1% CREAM 100GM, a pharmaceutical product, with a completion date of April 21, 2023. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,940.76 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream, a prescription medication, to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,205.68, is for the delivery of Pimecrolimus 1% Cream in 100 gram quantities. The contract is a Firm Fixed Price Delivery Order with a completion date of September 13, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,963.14 firm fixed price contract is for the supply of Pimecrolimus 1% Cream in 100g containers. There is no set-aside designation for this order, which has an ultimate completion date of August 21, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of...
This federal contract award, valued at $1,022.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pimecrolimus 1% Cream, a topical medication, with a final completion date of August 1, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,739.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of PIMECROLIMUS 1% Cream (30 grams). This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....